The Expanding Role of Nuclear Medicine and Molecular Imaging in Management of Neurodegenerative Disease

![Figure][1] Scott Holbrook, BS, CNMT, FSNMMI-TS There has been tremendous excitement regarding biomarkers that provide in vivo information on neurodegenerative diseases. Until now, diagnosis has been through clinical evaluation, which often leads to inconclusive findings or misdiagnosis.